Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Dopamine Prompts Nerve Tissue to Regrow

By HospiMedica staff writers
Posted on 30 Nov 2006
Dopamine, a neurotransmitter, has been integrated into a polymer that can help nerve tissue reconnect to the organ it once served.

Researchers at the Georgia Institute of Technology (Georgia Tech, Atlanta, USA) and Emory University (Atlanta, USA) discovered that they could integrate dopamine into a polymer to stimulate nerve tissues to send out new connections. More...
The new polymer was recognized by the neurons when used on a small piece of nerve tissue and it stimulated extensive neural growth. The implanted polymer did not cause any tissue scarring or nerve degeneration, allowing the nerve to grow in a hostile post-injury environment. As the nerve tissue reformed, the polymer degraded.

Dopamine's structure, which contains two hydroxyl groups, was found to be vital for the material's neuroactivity. Removing even one group caused a complete loss of the biologic activity. The researchers determined that dopamine was more effective at differentiating nerve cells than the two most popular materials for culturing nerves--
polylysine and laminin. This ability means that the material with dopamine may have a better chance to successfully repair damaged nerves. The success of dopamine has encouraged the team to set its sights on other neurotransmitters. The findings were published in the November 7, 2006, edition of the Proceedings of the [U.S.] National Academy of Sciences (PNAS).

"We showed that you could use a neurotransmitter as a building block of a polymer,” said lead author Yadong Wang, an assistant professor in the department of biomedical engineering at Georgia Tech. "Once integrated into the polymer, the transmitter can still elicit a specific response from nerve tissues.”

The discovery is the first step toward the eventual goal of implanting the new polymer into patients suffering from neurologic disorders, such as Alzheimer's, Parkinson's, or epilepsy, to help repair damaged nerves. The team's next step is to verify findings that the material stimulates the reformation of synapses in addition to regrowth.



Related Links:
Georgia Institute of Technology
Emory University

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.